HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Nakaraang pagsara
$14.52
Sakop ng araw
$14.26 - $14.62
Sakop ng taon
$9.12 - $72.37
Market cap
592.17M USD
Average na Volume
450.54K
P/E ratio
46.45
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 18.17M | 49,002.70% |
Gastos sa pagpapatakbo | 14.48M | 45.39% |
Net na kita | -30.70M | 32.17% |
Net profit margin | -168.96 | 99.86% |
Kita sa bawat share | -0.76 | 39.20% |
EBITDA | -39.45M | 21.32% |
Aktuwal na % ng binabayarang buwis | 6.75% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 690.22M | 70.06% |
Kabuuang asset | 757.16M | 66.40% |
Kabuuang sagutin | 50.43M | 47.87% |
Kabuuang equity | 706.73M | — |
Natitirang share | 40.62M | — |
Presyo para makapag-book | 0.83 | — |
Return on assets | -12.91% | — |
Return on capital | -13.52% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -30.70M | 32.17% |
Cash mula sa mga operasyon | -29.62M | 25.57% |
Cash mula sa pag-invest | -720.00K | -132.26% |
Cash mula sa financing | 17.00K | -99.52% |
Net change in cash | -30.33M | 17.10% |
Malayang cash flow | -25.12M | 4.96% |
Tungkol
Itinatag
2015
Headquarters
Website
Mga Empleyado
148
